These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
192 related articles for article (PubMed ID: 26866914)
1. The March towards a Vaccine for Congenital CMV: Rationale and Models. Bialas KM; Permar SR PLoS Pathog; 2016 Feb; 12(2):e1005355. PubMed ID: 26866914 [No Abstract] [Full Text] [Related]
2. Development of cytomegalovirus vaccines: prospects for prevention of congenital CMV infection. Pass RF; Burke RL Semin Pediatr Infect Dis; 2002 Jul; 13(3):196-204. PubMed ID: 12199616 [TBL] [Abstract][Full Text] [Related]
3. Comparison of vaccine strategies against congenital CMV infection in the guinea pig model. Schleiss MR J Clin Virol; 2008 Mar; 41(3):224-30. PubMed ID: 18060834 [TBL] [Abstract][Full Text] [Related]
4. Comparison of monovalent glycoprotein B with bivalent gB/pp65 (GP83) vaccine for congenital cytomegalovirus infection in a guinea pig model: Inclusion of GP83 reduces gB antibody response but both vaccine approaches provide equivalent protection against pup mortality. Swanson EC; Gillis P; Hernandez-Alvarado N; Fernández-Alarcón C; Schmit M; Zabeli JC; Wussow F; Diamond DJ; Schleiss MR Vaccine; 2015 Jul; 33(32):4013-8. PubMed ID: 26079615 [TBL] [Abstract][Full Text] [Related]
8. Vaccination with a Live Attenuated Cytomegalovirus Devoid of a Protein Kinase R Inhibitory Gene Results in Reduced Maternal Viremia and Improved Pregnancy Outcome in a Guinea Pig Congenital Infection Model. Schleiss MR; Bierle CJ; Swanson EC; McVoy MA; Wang JB; Al-Mahdi Z; Geballe AP J Virol; 2015 Oct; 89(19):9727-38. PubMed ID: 26178990 [TBL] [Abstract][Full Text] [Related]
9. Immunogenicity evaluation of DNA vaccines that target guinea pig cytomegalovirus proteins glycoprotein B and UL83. Schleiss MR; Bourne N; Jensen NJ; Bravo F; Bernstein DI Viral Immunol; 2000; 13(2):155-67. PubMed ID: 10892996 [TBL] [Abstract][Full Text] [Related]
10. Review of Mathematical Models of Vaccination for Preventing Congenital Cytomegalovirus Infection. Lanzieri TM; Gastañaduy PA; Gambhir M; Plotkin SA J Infect Dis; 2020 Mar; 221(Suppl 1):S86-S93. PubMed ID: 32134475 [TBL] [Abstract][Full Text] [Related]
12. Prospects for development and potential impact of a vaccine against congenital cytomegalovirus (CMV) infection. Schleiss MR J Pediatr; 2007 Dec; 151(6):564-70. PubMed ID: 18035130 [No Abstract] [Full Text] [Related]
13. An attenuated cytomegalovirus vaccine with a deletion of a viral chemokine gene is protective against congenital CMV transmission in a guinea pig model. Leviton MP; Lacayo JC; Choi KY; Hernandez-Alvarado N; Wey A; Schleiss MR Clin Dev Immunol; 2013; 2013():906948. PubMed ID: 24000289 [TBL] [Abstract][Full Text] [Related]
14. Nonprimate models of congenital cytomegalovirus (CMV) infection: gaining insight into pathogenesis and prevention of disease in newborns. Schleiss MR ILAR J; 2006; 47(1):65-72. PubMed ID: 16391432 [TBL] [Abstract][Full Text] [Related]
15. Progress on human cytomegalovirus vaccines for prevention of congenital infection and disease. Wang D; Fu TM Curr Opin Virol; 2014 Jun; 6():13-23. PubMed ID: 24632198 [TBL] [Abstract][Full Text] [Related]
16. Animal models of congenital cytomegalovirus infection: an overview of progress in the characterization of guinea pig cytomegalovirus (GPCMV). Schleiss MR J Clin Virol; 2002 Aug; 25 Suppl 2():S37-49. PubMed ID: 12361755 [TBL] [Abstract][Full Text] [Related]
17. Additive Protection against Congenital Cytomegalovirus Conferred by Combined Glycoprotein B/pp65 Vaccination Using a Lymphocytic Choriomeningitis Virus Vector. Schleiss MR; Berka U; Watson E; Aistleithner M; Kiefmann B; Mangeat B; Swanson EC; Gillis PA; Hernandez-Alvarado N; Fernández-Alarcón C; Zabeli JC; Pinschewer DD; Lilja AE; Schwendinger M; Guirakhoo F; Monath TP; Orlinger KK Clin Vaccine Immunol; 2017 Jan; 24(1):. PubMed ID: 27795301 [TBL] [Abstract][Full Text] [Related]
18. Vaccine development to prevent cytomegalovirus disease: report from the National Vaccine Advisory Committee. Arvin AM; Fast P; Myers M; Plotkin S; Rabinovich R; Clin Infect Dis; 2004 Jul; 39(2):233-9. PubMed ID: 15307033 [TBL] [Abstract][Full Text] [Related]
19. The guinea pig cytomegalovirus model of congenital human cytomegalovirus infection. Bia FJ; Miller SA; Davidson KH Birth Defects Orig Artic Ser; 1984; 20(1):233-41. PubMed ID: 6329364 [No Abstract] [Full Text] [Related]
20. Protection against congenital cytomegalovirus (CMV) disease, conferred by a replication-disabled, bacterial artificial chromosome (BAC)-based DNA vaccine. Schleiss MR; Stroup G; Pogorzelski K; McGregor A Vaccine; 2006 Sep; 24(37-39):6175-86. PubMed ID: 16879902 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]